Description

Tamai et al reported a severity index for evaluating a patient with dystrophic epidermolysis bullosa (DEB). The authors are from the Japanese Study Group for Rare Intractable Skin Diseases.


Parameters:

(1) de novo blister

(2) area of blistering (percent body surface area, BSA)

(3) oral blister

(4) scar formation

(5) pseudosyndactyly

(6) esophageal stenosis

(7) height as percent of normal

(8) weight as percent of normal

(9) anemia (hemoglobin as percent of normal hemoglobin)

(10) serum protein as a percent of normal

(11) bone minerals as percent of normal

(12) infection with methicillin resistant Staphylococcus aureus (MRSA)

 

Parameter

Findings

Points

de novo blisters

none

0

 

1 to 3 per week

1

 

>= 4 per week

2

 

every day

3

area of blistering

none

0

 

1 - 4%

1

 

5 - 15%

2

 

> 15%

3

oral blister

none

0

 

1 or 2 per month

1

 

several per month

2

 

persistent

3

scar formation

none

0

 

mild

1

 

intermittent

2

 

severe

3

pseudosyndactyly

none

0

 

mild

1

 

intermittent

2

 

severe

3

esophageal stenosis

none

0

 

dysphagia

1

 

unable to eat solid material

2

 

unable to take liquids

3

height

100%

0

 

91 - 99%

1

 

80 - 90%

2

 

< 80%

3

weight

100%

0

 

91 - 99%

1

 

80 - 90%

2

 

< 80%

3

anemia

100%

0

 

91 - 99%

1

 

80 - 90%

2

 

< 80%

3

serum protein

100%

0

 

91 - 99%

1

 

80 - 90%

2

 

< 80%

3

bone minerals

100%

0

 

91 - 99%

1

 

80 - 90%

2

 

< 80%

3

infection with MRSA

none

0

 

local, inactive infection

1

 

local, active infection

2

 

systemic

3

 

total score =

= SUM(points for all 12 parameters)

 

Interpretation:

• minimum score: 0

• maximum score: 36

 

Total Score

Disease Severity

0 - 10

mild

11 - 18

moderate

19 - 26

severe

 

A patient is classified as having severe disease if the score is >= 1 and one or more of the following:

(1) squamous cell carcinoma

(2) reactive amyloidosis


To read more or access our algorithms and calculators, please log in or register.